Clincosm LogoSign in Get a demo

Solid Tumors

Showing 1 - 25 of 598
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial (GS-9911, Zimberelimab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Oct 9, 2023

Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)

Not yet recruiting
  • Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +4 more
  • MK-2870
  • +2 more
  • (no location specified)
Sep 15, 2023

Solid Tumors Trial in United States (ADRX-0706)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +3 more
Sep 12, 2023

Solid Tumors, Head Neck Cancer Trial in Shijiazhuang (SYH2051 tablets, Intensity-Modulated Radiation Therapy (IMRT))

Recruiting
  • Solid Tumors
  • Head and Neck Cancer
  • SYH2051 tablets
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Shijiazhuang, Hebei, China
    Clinical Trials Information Group
Aug 21, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Solid Tumors Trial in Charlottesville (XmAb662, Keytruda® (pembrolizumab))

Recruiting
  • Solid Tumors
  • XmAb662
  • Keytruda® (pembrolizumab)
  • Charlottesville, Virginia
    University Of Virginia Comprehensive Cancer Center
Aug 10, 2023

Solid Tumors Trial in Budapest ([14C] Subasumstat, Subasumstat)

Not yet recruiting
  • Solid Tumors
  • Budapest, Hungary
  • +1 more
Jul 28, 2023

Solid Tumors, Advanced Solid Tumors, Metastatic Cancer Trial in Korea, Republic of (bevacizumab, erlotinib)

Recruiting
  • Solid Tumors
  • +2 more
  • Daejeon, Chungcheongnam-do, Korea, Republic of
  • +9 more
Jun 6, 2023

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
May 17, 2023

Solid Tumors Trial (BI 1821736)

Not yet recruiting
  • Solid Tumors
  • BI 1821736
  • (no location specified)
Apr 21, 2023

Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors Trial (INCA33890)

Not yet recruiting
  • Solid Tumors
  • +2 more
  • (no location specified)
Apr 26, 2023

Solid Tumors Trial in Waratah (IBI334)

Not yet recruiting
  • Solid Tumors
  • Waratah, New South Wales, Australia
    Westmead Hospital
Mar 7, 2023

Solid Tumors Trial in Chongqing (F520, Lenvatinib)

Recruiting
  • Solid Tumors
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Feb 13, 2023

Colorectal Cancer, Solid Tumors Trial (SNDX-5613, Chemotherapy)

Not yet recruiting
  • Colorectal Cancer
  • Solid Tumors
  • (no location specified)
Feb 15, 2023

Prospective Procurement of Tumor Tissue to Identify Novel

Enrolling by invitation
  • Solid Tumors
  • +7 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Solid Tumors Trial in Worldwide (RO7300490, Atezolizumab)

    Recruiting
    • Solid Tumors
    • København Ø, Denmark
    • +10 more
    Jan 31, 2023

    Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

    Recruiting
    • Solid Tumors
    • +5 more
    • Durham, North Carolina
    • +2 more
    Jan 31, 2023

    Solid Tumors Trial (Bemarituzumab)

    Recruiting
    • Solid Tumors
    • Duarte, California
    • +54 more
    Feb 1, 2023

    Solid Tumors Trial in Worldwide (RO7296682, Atezolizumab)

    Recruiting
    • Solid Tumors
    • Duarte, California
    • +12 more
    Jan 31, 2023

    Solid Tumors Trial in Worldwide (RO7284755, Atezolizumab)

    Recruiting
    • Solid Tumors
    • Bruxelles, Belgium
    • +12 more
    Jan 23, 2023

    Tumors, Solid Tumors Trial run by the National Cancer Institute (NCI) (aza-TdC)

    Recruiting
    • Neoplasms
    • Solid Tumors
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

    Active, not recruiting
    • Ovarian Cancer
    • +3 more
    • Duarte, California
    • +6 more
    Jan 21, 2023